
Cardinal Health, Inc.: updates and filings
Price
$272.34
November 19, 2026Market cap $63.3B
What Ploutos Investor adds for Cardinal Health
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from FY2010
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Feb 2, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
April 2026
March 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Shareholder voteForm8-K
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operations, Regulation FD disclosureForm8-K
- Oct 1, 2026Regulation FD disclosureForm8-K
- Sep 21, 2026Annual report to shareholdersfor the period to Jun 30, 2026FormARS
- Sep 21, 2026Additional annual meeting materialFormDEFA14A
- Sep 21, 2026Annual meeting proxy statementFormDEF 14A
- Aug 13, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 11, 2026Annual reportfor the period to Jun 30, 2026Form10-K
- Aug 11, 2026Results of operations, Regulation FD disclosureForm8-K
- Aug 11, 2026Material agreement entered, material agreement ended, new material financial obligationForm8-K
- Aug 5, 2026Officer or director changeForm8-K
- Jun 23, 2026Employee stock plan reportfor the period to Dec 31, 2025Form11-K
- Jun 23, 2026Employee stock plan reportfor the period to Dec 31, 2025Form11-K
- Jun 1, 2026Conflict minerals reportFormSD
- Apr 30, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 30, 2026Results of operations, Regulation FD disclosureForm8-K
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Mar 26, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 23, 2026Officer or director change, Regulation FD disclosureForm8-K
- Mar 5, 2026Officer or director changeForm8-K
- Feb 5, 2026Quarterly reportfor the period to Dec 31, 2025Form10-Q
- Feb 5, 2026Results of operations, Regulation FD disclosureForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | 8-K | Shareholder vote | Document |
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Oct 1, 2026 | 8-K | Regulation FD disclosure | Document |
| Sep 21, 2026 | ARS | Annual report to shareholdersfor the period to Jun 30, 2026 | Document |
| Sep 21, 2026 | DEFA14A | Additional annual meeting material | Document |
| Sep 21, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Aug 13, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 11, 2026 | 10-K | Annual reportfor the period to Jun 30, 2026 | Document |
| Aug 11, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Aug 11, 2026 | 8-K | Material agreement entered, material agreement ended, new material financial obligation | Document |
| Aug 5, 2026 | 8-K | Officer or director change | Document |
| Jun 23, 2026 | 11-K | Employee stock plan reportfor the period to Dec 31, 2025 | Document |
| Jun 23, 2026 | 11-K | Employee stock plan reportfor the period to Dec 31, 2025 | Document |
| Jun 1, 2026 | SD | Conflict minerals report | Document |
| Apr 30, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 30, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Mar 26, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 23, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Mar 5, 2026 | 8-K | Officer or director change | Document |
| Feb 5, 2026 | 10-Q | Quarterly reportfor the period to Dec 31, 2025 | Document |
| Feb 5, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Feb 9, 1994: every report, 8-K, meeting and letter. Of its other filings (1,147 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 59.
The full analysis
What do Cardinal Health's filings show?
The filings are where every one of Cardinal Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.